sTNF‐RII: is it useful for the early diagnosis of rejection and for prognosis after renal transplantation?

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Transplant International

• Publication date

  2002-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1432-2277.2002.tb00175.xPMID 12122509
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TREATMENT OF SEPTIC SHOCK WITH THE TUMOR NECROSIS FACTOR RECEPTOR : Fc FUSION PROTEIN C

  2000cited by this paper
• Antiinflammatory properties of mycophenolate mofetil in murine endotoxemia: inhibition of TNF-alpha and upregulation of IL-10 release.

  1999cited by this paper
• Clinical trials for severe sepsis. Past failures, and future hopes.

  1999cited by this paper
• Treatment of Sepsis

  1999cited by this paper
• Apoptosis and expression of cytotoxic T lymphocyte effector molecules in renal allografts.

  1999cited by this paper
• Analysis of intragraft cytokine expression during early reperfusion after liver transplantation using semi-quantitative RT-PCR.

  1998cited by this paper
• Endothelial activation and cytokine expression in human acute cardiac allograft rejection

  1998cited by this paper
• The Role of Tumor Necrosis Factor-α Receptors in Atherosclerosis.

  1998cited by this paper
• Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients.

  1997cited by this paper
• p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.

  1997cited by this paper
• p55 Tumor Necrosis Factor Receptor Fusion Protein in the Treatment of Patients With Severe Sepsis and Septic Shock: A Randomized Controlled Multicenter Trial

  1997cited by this paper
• Urine cytology and the diagnosis of renal allograft rejection. II. Studies using immunostaining.

  1997cited by this paper
• Urine cytology and the diagnosis of renal allograft rejection. I. Studies using conventional staining.

  1997cited by this paper
• Anti-inflammatory cytokine levels in patients with septic shock.

  1997cited by this paper
• Transplantation immunology: a brief update.

  1997cited by this paper
• Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group.

  1996cited by this paper
• Cytokine pattern during rejection and infection after liver transplantation--improvements in postoperative monitoring?

  1996influential reference
• The Th1/Th2 paradigm and the allograft response.

  1996cited by this paper
• The release of cytokines, adhesion molecules, and extracellular matrix parameters during and after reperfusion in human liver transplantation.

  1996cited by this paper
• In vivo soluble tumor necrosis factor receptor release in OKT3-treated patients. Differential regulation of TNF-sR55 and TNF-sR75.

  1995cited by this paper
• Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF.

  1995cited by this paper
• Inhibition Of The Effects Of Tnf In Renal Allograft Recipients Using Recombinant Human Dimeric Tumor Necrosis Factor Receptors

  1995cited by this paper
• Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis

  1995influential reference
• Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal allograft rejection.

  1995cited by this paper
• Soluble tumor necrosis factor-receptors are not a useful marker of acute allograft rejection: a study in patients with renal or cardiac allografts

  1995influential reference
• Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients.

  1994cited by this paper
• Increase of sTNF receptor levels in acute renal allograft rejection after treatment with OKT3.

  1994cited by this paper
• Value of serum soluble tumour necrosis factor concentrations in the diagnosis and prognosis of renal graft rejection.

  1994cited by this paper
• Natural serum TNF antagonists in end-stage renal failure and following renal transplantation.

  1994cited by this paper
• Tumor necrosis factor (TNF) alpha quantification by ELISA and bioassay: effects of TNF alpha-soluble TNF receptor (p55) complex dissociation during assay incubations.

  1994cited by this paper
• Serum levels of the soluble receptor for tumor necrosis factor in patients with renal disease

  1994influential reference
• Tumor Necrosis Factor (TNF) α quantification by ELISA and bioassay: effects of TNFα-soluble TNF receptor (p55) complex dissociation during assay incubations

  1994cited by this paper
• Hepatic ischemia/reperfusion injury: importance of oxidant/tumor necrosis factor interactions.

  1994cited by this paper
• SERUM AND URINE IL‐6 AND TNF-α IN RENAL TRANSPLANT RECIPIENTS WITH GRAFT DYSFUNCTION

  1993cited by this paper
• Serum and urine IL-6 and TNF-alpha in renal transplant recipients with graft dysfunction.

  1993cited by this paper
• PRODUCTION OF CYTOKINES (TNF‐ALPHA, IL‐1‐BETA) AND ENDOTHELIAL CELL ACTIVATION IN HUMAN LIVER ALLOGRAFT REJECTION1

  1993cited by this paper
• The two different receptors for tumor necrosis factor mediate distinct cellular responses.

  1991cited by this paper
• Evaluation of measurement of human TNF in plasma by ELISA.

  1991cited by this paper
• The divergent receptors for TNF.

  1990cited by this paper
• Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.

  1990cited by this paper
• The mediators of inflammation (interleukin 1, interferon-tau, and tumor necrosis factor) and their relevance to rejection.

  1989cited by this paper
• Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection

  1987cited by this paper

• TFNR2 in Ischemia-Reperfusion Injury, Rejection, and Tolerance in Transplantation

  2022cites this paper
• Xenotransplantation literature update, November/December 2020

  2021cites this paper
• Characterization of putative regulatory isoforms of porcine tumor necrosis factor receptor 2 in endothelial cells

  2020cites this paper
• Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis

  2015cites this paper
• TNF receptors: signaling pathways and contribution to renal dysfunction.

  2015cites this paper
• Association between graft function and serum TNF-α, TNFR1 and TNFR2 levels in patients with kidney transplantation

  2015cites this paper
• Tumor Necrosis Factor Receptor 2: Its Contribution to Acute Cellular Rejection and Clear Cell Renal Carcinoma

  2013cites this paper
• Identification of soluble and membrane‐bound isoforms of porcine tumor necrosis factor receptor 2

  2011cites this paper
• HLA Class I (ABC) Upregulation on Peripheral Blood CD3+/CD8+ T Lymphocyte Surface Is a Potential Predictor of Acute Rejection in Renal Transplantation

  2009cites this paper
• Lymphocytic HLA-A mRNA is a reliable indicator of acute rejection in renal transplantation.

  2008cites this paper
• Dialysis and Transplantation

  2001cites this paper